Appili Therapeutics Inc stock advanced on Tuesday.
Today in trading, shares of Appili Therapeutics Inc opened at $0.07 and closed at $0.07. prices ranged from a low of $0.07 to a high of $0.07.
Share prices advanced 7.69 percent from the previous day's close of $0.07.
Today across North America, the TSX Composite closed 0.25% at 19669.17, the S&P 500 closed -0.12% at 4140.06, the Dow Jones Industrial Average closed 0.09% at 32832.54 and the Nasdaq Composite closed -0.10% at 12644.46.
Appili Therapeutics Inc has listed on the TSX stock exchange under the ticker APLI.TO.
Trading volume was 49,027 on 3 total trades, while having an average volume of 51,348 in the last five days.
The TSX overall saw 1,735 price advancers against 3,893 declines and 323 unchanged.
During the prior 52 weeks, APLI.TO has traded as high as $1.14 (September 30,2021) and low as $0.06 (July 22,2022). Moreover, in the last 12 months, Appili Therapeutics Inc's shares have plummeted -90.14 percent, while this year, they have shrunken -39.13%.
Following today's trading, Appili Therapeutics Inc has a market capitalization of $7.88 million on a float of 121,266 shares outstanding. Its annual EPS is $-0.38.
Appili Therapeutics Inc is a None company headquartered in Halifax, US.
Currently, Appili Therapeutics Inc has an average recommendation of "Hold" based on 2.00 analysts according to Zacks. Currently, there are 2 hold ratings for the stock.
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..